HIGH-DOSE CHEMOTHERAPY WITH BLOOD OR BONE MARROW TRANSPLANTS FOR RHABDOMYOSARCOMA

Rhabdomyosarcoma (RMS), the most common soft-tissue sarcoma in children, is cured with conventional therapy in 70%. However, 5 year survival for those who relapse is about 30% and drops to about 15% for those with unfavorable histologies (alveolar/undifferentiated subtypes). We describe outcomes of...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Stiff, Patrick J., Agovi, Manza-A., Antman, Karen H., Blaise, Didier, Camitta, Bruce M., Cairo, Mitchell S., Childs, Richard W., Edwards, John R, Gale, Robert Peter, Hale, Gregory A., Lazarus, Hillard M., Arora, Mukta
Médium: Artigo
Jazyk:Inglês
Vydáno: 2009
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2838953/
https://ncbi.nlm.nih.gov/pubmed/19961947
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2009.11.020
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky